Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Perfect

Showing results (311-320 of 328) with videos related to

Pageof 33
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 13, 2015
The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infectionsMartin Jaeger, Robin van der Lee, Shih-Chin Cheng, et al.
The Lancet. Infectious Diseases|December 17, 2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidancePhilipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, et al.
The Journal of Clinical Investigation|November 2, 2013
CX3CR1-dependent renal macrophage survival promotes Candida control and host survivalMichail S Lionakis, Muthulekha Swamydas, Brett G Fischer, et al.
Mbio|October 27, 2021
Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the InfectionDong-Hoon Yang, Matthew R England, Helene Salvator, et al.
Genetics|July 7, 2017
Tracing Genetic Exchange and Biogeography of <i>Cryptococcus neoformans</i> var. <i>grubii</i> at the Global Population LevelJohanna Rhodes, Christopher A Desjardins, Sean M Sykes, et al.
Nature Communications|January 10, 2013
Functional genomics identifies type I interferon pathway as central for host defense against Candida albicansSanne P Smeekens, Aylwin Ng, Vinod Kumar, et al.
The New England Journal of Medicine|October 30, 2009
Human dectin-1 deficiency and mucocutaneous fungal infectionsBart Ferwerda, Gerben Ferwerda, Theo S Plantinga, et al.
Cell|May 23, 2023
C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infectionJigar V Desai, Dhaneshwar Kumar, Tilo Freiwald, et al.
Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Pageof 33

Showing results (311-320 of 328) with videos related to

Sort By:
Pageof 33
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 13, 2015
The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infectionsMartin Jaeger, Robin van der Lee, Shih-Chin Cheng, et al.
The Lancet. Infectious Diseases|December 17, 2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidancePhilipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, et al.
The Journal of Clinical Investigation|November 2, 2013
CX3CR1-dependent renal macrophage survival promotes Candida control and host survivalMichail S Lionakis, Muthulekha Swamydas, Brett G Fischer, et al.
Mbio|October 27, 2021
Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the InfectionDong-Hoon Yang, Matthew R England, Helene Salvator, et al.
Genetics|July 7, 2017
Tracing Genetic Exchange and Biogeography of <i>Cryptococcus neoformans</i> var. <i>grubii</i> at the Global Population LevelJohanna Rhodes, Christopher A Desjardins, Sean M Sykes, et al.
Nature Communications|January 10, 2013
Functional genomics identifies type I interferon pathway as central for host defense against Candida albicansSanne P Smeekens, Aylwin Ng, Vinod Kumar, et al.
The New England Journal of Medicine|October 30, 2009
Human dectin-1 deficiency and mucocutaneous fungal infectionsBart Ferwerda, Gerben Ferwerda, Theo S Plantinga, et al.
Cell|May 23, 2023
C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infectionJigar V Desai, Dhaneshwar Kumar, Tilo Freiwald, et al.
Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Pageof 33